These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24382192)

  • 1. Non-compliance and therapeutic inertia: two unanswered questions in clinical practice.
    Pallarés-Carratalá V; Pascual Pérez R
    Curr Med Res Opin; 2014 May; 30(5):839-40. PubMed ID: 24382192
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological compliance in the treatment of arterial hypertension. A review of studies published between 1975 and 2011].
    Espinosa García J; Martell Claros N; Llerena Ruiz A; Fernández Bergés Gurrea D
    Semergen; 2012; 38(5):292-300. PubMed ID: 23544776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmaceutical counseling and adherence to antihypertensive treatment: Preliminary study].
    Limaylla-La-Torre M
    Rev Peru Med Exp Salud Publica; 2017; 34(2):343-344. PubMed ID: 29177399
    [No Abstract]   [Full Text] [Related]  

  • 4. Adherence to medication: the importance of research in primary care.
    Prado JC; Mion D
    Am J Hypertens; 2010 Feb; 23(2):109. PubMed ID: 20087323
    [No Abstract]   [Full Text] [Related]  

  • 5. A community-based intervention program to effectively treat hypertension in developing countries.
    Waeber B; Feihl F
    J Hypertens; 2013 Jan; 31(1):47-8. PubMed ID: 23221931
    [No Abstract]   [Full Text] [Related]  

  • 6. Depression and clinical inertia in patients with uncontrolled hypertension.
    Moise N; Davidson KW; Chaplin W; Shea S; Kronish I
    JAMA Intern Med; 2014 May; 174(5):818-9. PubMed ID: 24615061
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary to: Cost of poor adherence to anti-hypertensive therapy in five European countries.
    Gandjour A
    Eur J Health Econ; 2015 Nov; 16(8):907. PubMed ID: 26216671
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country.
    Mennini FS; Marcellusi A; von der Schulenburg JM; Gray A; Levy P; Sciattella P; Soro M; Staffiero G; Zeidler J; Maggioni A; Schmieder RE
    Eur J Health Econ; 2015 Nov; 16(8):909-11. PubMed ID: 26231984
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic adherence. How difficult it is to comply!].
    Buitrago F
    Aten Primaria; 2011 Jul; 43(7):343-4. PubMed ID: 21658815
    [No Abstract]   [Full Text] [Related]  

  • 10. Kidney disease and antihypertensive medication adherence: the need for improved measurement tools.
    Chang TI; Winkelmayer WC
    Am J Kidney Dis; 2010 Sep; 56(3):423-6. PubMed ID: 20728787
    [No Abstract]   [Full Text] [Related]  

  • 11. Author's reply: To PMID 22641577.
    Hsieh JY
    J Nephrol; 2013; 26(2):417-8. PubMed ID: 23515970
    [No Abstract]   [Full Text] [Related]  

  • 12. High adherence and concordance within a clinical trial of antihypertensives.
    Horne R; Clatworthy J; Hankins M;
    Chronic Illn; 2010 Dec; 6(4):243-51. PubMed ID: 20610466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Adherence Codes in the New ICD-10: Need for Prospective Trials.
    Baines LS; Little DJ; Nee R; Jindal RM
    Am J Nephrol; 2015; 42(2):148-50. PubMed ID: 26398206
    [No Abstract]   [Full Text] [Related]  

  • 14. Antihypertensive medication adherence and subsequent healthcare utilization and costs.
    Pittman DG; Tao Z; Chen W; Stettin GD
    Am J Manag Care; 2010 Aug; 16(8):568-76. PubMed ID: 20712390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Resistant hypertension by unadvertised non-compliance detected by psychiatric expertise and drug dosages].
    Didier R; Gilard M; Denolle T
    Ann Cardiol Angeiol (Paris); 2018 Jun; 67(3):222-225. PubMed ID: 29753423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-compliance and inertia in hypertensive Spaniards at high cardiovascular risk: CUMPLE study.
    Márquez-Contreras E; Gil-Guillén VF; De La Figuera-Von Wichmann M; Franch-Nadal J; Llisterri-Caro JL; Martell-Claros N; Martin-De Pablos JL; Casado-Martinez JJ; Bertomeu-Gonzalez V; Pertusa Martínez S; Carratalá-Munuera C; Orozco-Beltrán D; Lopez-Pineda A;
    Curr Med Res Opin; 2014 Jan; 30(1):11-7. PubMed ID: 24111509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The possibility of unmeasured confounding variables in observational studies: a forgotten fact?
    Byrd JB; Ho PM
    Heart; 2011 Nov; 97(22):1815-6. PubMed ID: 21795300
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors associated with antihypertensive drug compliance in 83,884 Chinese patients: a cohort study.
    Wong MC; Jiang JY; Griffiths SM
    J Epidemiol Community Health; 2010 Oct; 64(10):895-901. PubMed ID: 20693495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to antihypertensive agents and blood pressure control in chronic kidney disease.
    Schmitt KE; Edie CF; Laflam P; Simbartl LA; Thakar CV
    Am J Nephrol; 2010; 32(6):541-8. PubMed ID: 21042012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor adherence to antihypertensive drugs.
    Hameed MA; Dasgupta I; Gill P
    BMJ; 2016 Jul; 354():i3268. PubMed ID: 27444756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.